127 related articles for article (PubMed ID: 38150107)
21. Inhibition of phosphodiesterase-4 decreases ethanol intake in mice.
Hu W; Lu T; Chen A; Huang Y; Hansen R; Chandler LJ; Zhang HT
Psychopharmacology (Berl); 2011 Nov; 218(2):331-9. PubMed ID: 21509503
[TBL] [Abstract][Full Text] [Related]
22. Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1/Akt pathway.
Li Q; Peng Y; Fan L; Xu H; He P; Cao S; Li J; Chen T; Ruan W; Chen G
Biomed Pharmacother; 2018 Mar; 99():947-955. PubMed ID: 29710495
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase-4 inhibition reduces ECLS-induced vascular permeability and improves microcirculation in a rodent model of extracorporeal resuscitation.
Wollborn J; Siemering S; Steiger C; Buerkle H; Goebel U; Schick MA
Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H751-H761. PubMed ID: 30681364
[TBL] [Abstract][Full Text] [Related]
24. Rolipram-induced improvement of cognitive function correlates with changes in hippocampal CREB phosphorylation, BDNF and Arc protein levels.
Zhong Y; Zhu Y; He T; Li W; Yan H; Miao Y
Neurosci Lett; 2016 Jan; 610():171-6. PubMed ID: 26552011
[TBL] [Abstract][Full Text] [Related]
25. PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis.
Wiescholleck V; Manahan-Vaughan D
Transl Psychiatry; 2012 Mar; 2(3):e89. PubMed ID: 22832854
[TBL] [Abstract][Full Text] [Related]
26. Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress.
Ortiz JL; Milara J; Lluch J; De Diego A; Sanz C; Cortijo J
Allergy; 2013 Jan; 68(1):64-73. PubMed ID: 23121078
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25-35 in rats.
Zhuo Y; Guo H; Cheng Y; Wang C; Wang C; Wu J; Zou Z; Gan D; Li Y; Xu J
Metab Brain Dis; 2016 Aug; 31(4):779-91. PubMed ID: 26920899
[TBL] [Abstract][Full Text] [Related]
28. Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Song G; Zhu X; Li J; Hu D; Zhao D; Liao Y; Lin J; Zhang LH; Cui ZN
Bioorg Med Chem; 2017 Oct; 25(20):5709-5717. PubMed ID: 28888661
[TBL] [Abstract][Full Text] [Related]
29. The phosphodiesterase-4 inhibitor rolipram reverses Aβ-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats.
Wang C; Yang XM; Zhuo YY; Zhou H; Lin HB; Cheng YF; Xu JP; Zhang HT
Int J Neuropsychopharmacol; 2012 Jul; 15(6):749-66. PubMed ID: 21733236
[TBL] [Abstract][Full Text] [Related]
30. Effect of co-administration of two different phosphodiesterase inhibitors and a β
Linhares BL; Nascimento NRF; Gonzaga-Silva LF; Santos CF; Moraes MO; Marinho LB; Silva APG; Fonteles MC; Reges R
Eur J Pharmacol; 2018 Aug; 833():425-431. PubMed ID: 29913125
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A
J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804
[TBL] [Abstract][Full Text] [Related]
32. PDE type-4 inhibition increases L-type Ca(2+) currents, action potential firing, and quantal size of exocytosis in mouse chromaffin cells.
Marcantoni A; Carabelli V; Vandael DH; Comunanza V; Carbone E
Pflugers Arch; 2009 Mar; 457(5):1093-110. PubMed ID: 18779976
[TBL] [Abstract][Full Text] [Related]
33. Prevention of cerebral ischemia-induced memory deficits by inhibition of phosphodiesterase-4 in rats.
Li LX; Cheng YF; Lin HB; Wang C; Xu JP; Zhang HT
Metab Brain Dis; 2011 Mar; 26(1):37-47. PubMed ID: 21327879
[TBL] [Abstract][Full Text] [Related]
34. PDE4 inhibitor rolipram inhibits the expression of microsomal prostaglandin E synthase-1 by a mechanism dependent on MAP kinase phosphatase-1.
Tuure L; Hämäläinen M; Moilanen E
Pharmacol Res Perspect; 2017 Dec; 5(6):. PubMed ID: 29226622
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of phosphodiesterase-4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP-cytokine-Cx43 signaling in mice.
Zhang FF; Wang H; Zhou YM; Yu HY; Zhang M; Du X; Wang D; Zhang F; Xu Y; Zhang JG; Zhang HT
CNS Neurosci Ther; 2022 May; 28(5):749-760. PubMed ID: 35156776
[TBL] [Abstract][Full Text] [Related]
36. A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI.
Iannotti CA; Clark M; Horn KP; van Rooijen N; Silver J; Steinmetz MP
Exp Neurol; 2011 Jul; 230(1):3-15. PubMed ID: 20338167
[TBL] [Abstract][Full Text] [Related]
37. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.
Togo S; Liu X; Wang X; Sugiura H; Kamio K; Kawasaki S; Kobayashi T; Ertl RF; Ahn Y; Holz O; Magnussen H; Fredriksson K; Skold CM; Rennard SI
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L959-69. PubMed ID: 19304913
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of phosphodiesterase 4 enhances clitoral and vaginal blood flow responses to dorsal clitoral nerve stimulation or PGE1 in anesthetized female rats.
Castiglione F; Bergamini A; Russo A; La Croce G; Castagna G; Colciago G; Salonia A; Rigatti P; Montorsi F; Hedlund P
J Sex Med; 2013 Apr; 10(4):939-50. PubMed ID: 23347325
[TBL] [Abstract][Full Text] [Related]
39. Characterization and optimization of bilosomes for oral vaccine delivery.
Wilkhu JS; McNeil SE; Anderson DE; Perrie Y
J Drug Target; 2013 Apr; 21(3):291-299. PubMed ID: 30952177
[TBL] [Abstract][Full Text] [Related]
40. Permeation enhancers loaded bilosomes for improved intestinal absorption and cytotoxic activity of doxorubicin.
Sultan AA; Saad GA; El Maghraby GM
Int J Pharm; 2023 Jan; 630():122427. PubMed ID: 36435504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
